Table 2.
Predictors of mortality | ||||
---|---|---|---|---|
Predictors | Univariate |
Multivariate (n = 372) |
||
OR (95% CI) | p-value | OR (95% CI) | p-value | |
Age: < 60 years | 1.0 (Ref.) | 1.0 (Ref.) | ||
60–70 years | 3.5 (1.3–9.6) | 0.02 | 3.4 (1.2–9.4) | 0.02 |
70–80 years | 27.0 (11–66.2) | <0.0001 | 25.2 (9.8–64.4) | <0.0001 |
> 80 years | 40.5 (16–102.6) | <0.0001 | 39.5 (14.7–106.5) | <0.0001 |
Gender: male vs female | 1.3 (0.8–2.1) | p = 0.2 | 1.2 (0.6–2.2) | 0.6 |
Hypertension | 2.2 (1.4–3.3) | <0.0001 | 0.9 (0.5–1.7) | 0.7 |
Cardiovascular diseases | 3.8 (2.4–5.9) | <0.0001 | 1.9 (1.1–3.3) | 0.02 |
Diabetes | 2.6 (1.6–4.3) | <0.0001 | 1.1 (0.5–2.4) | 0.7 |
Respiratory disease | 1.9 (1–3.5) | 0.04 | 0.8 (0.3–2.0) | 0.7 |
Malignancy | 2 (1.1–3.6) | 0.02 | 1.0 (0.4–2.3) | 0.9 |
Time to ED | 0.95 (0.92–0.97) | <0.0001 | 0.98 (0.92–1-04) | 0.5 |
ACEi | 1.4 (0.8–2.5) | 0.19 | 0.5 (0.3–1.0) | 0.06 |
ARB | 1.3 (0.7–2.4) | 0.38 | 1.1 (0.5–2.8) | 0.8 |
Therapy: LMWH | 0.5 (0.3–0.8) | <0.001 | 0.4 (0.2–0.6) | <0.0001 |
Time to ED: time from symptoms onset to ED access. LOS: length of hospitalization. LMWH: low-molecular weight heparin; ACEi: angiotensin-converting enzyme inhibitor; ARB: angiotensin II receptor blocker.